nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—hypertension—focal segmental glomerulosclerosis	0.928	1	CtDrD
Acebutolol—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0256	0.515	CbGbCtD
Acebutolol—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0241	0.485	CbGbCtD
Acebutolol—Thrombocytopenic purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.0641	CcSEcCtD
Acebutolol—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.000715	0.0324	CcSEcCtD
Acebutolol—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.000578	0.0262	CcSEcCtD
Acebutolol—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.000538	0.0244	CcSEcCtD
Acebutolol—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.000533	0.0242	CcSEcCtD
Acebutolol—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.000514	0.0233	CcSEcCtD
Acebutolol—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00051	0.0231	CcSEcCtD
Acebutolol—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.000508	0.023	CcSEcCtD
Acebutolol—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.000493	0.0224	CcSEcCtD
Acebutolol—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.000491	0.0223	CcSEcCtD
Acebutolol—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.000474	0.0215	CcSEcCtD
Acebutolol—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.000456	0.0207	CcSEcCtD
Acebutolol—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.000409	0.0185	CcSEcCtD
Acebutolol—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.000389	0.0176	CcSEcCtD
Acebutolol—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.000379	0.0172	CcSEcCtD
Acebutolol—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.000373	0.0169	CcSEcCtD
Acebutolol—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00037	0.0168	CcSEcCtD
Acebutolol—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000361	0.0163	CcSEcCtD
Acebutolol—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000334	0.0151	CcSEcCtD
Acebutolol—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000331	0.015	CcSEcCtD
Acebutolol—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00033	0.015	CcSEcCtD
Acebutolol—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000327	0.0148	CcSEcCtD
Acebutolol—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000321	0.0145	CcSEcCtD
Acebutolol—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00031	0.0141	CcSEcCtD
Acebutolol—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000309	0.014	CcSEcCtD
Acebutolol—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000302	0.0137	CcSEcCtD
Acebutolol—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0003	0.0136	CcSEcCtD
Acebutolol—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000299	0.0135	CcSEcCtD
Acebutolol—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000294	0.0133	CcSEcCtD
Acebutolol—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000286	0.0129	CcSEcCtD
Acebutolol—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000273	0.0124	CcSEcCtD
Acebutolol—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000269	0.0122	CcSEcCtD
Acebutolol—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000261	0.0118	CcSEcCtD
Acebutolol—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00026	0.0118	CcSEcCtD
Acebutolol—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000253	0.0115	CcSEcCtD
Acebutolol—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000247	0.0112	CcSEcCtD
Acebutolol—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000247	0.0112	CcSEcCtD
Acebutolol—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000247	0.0112	CcSEcCtD
Acebutolol—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000246	0.0111	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000245	0.0111	CcSEcCtD
Acebutolol—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000244	0.0111	CcSEcCtD
Acebutolol—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000239	0.0108	CcSEcCtD
Acebutolol—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000237	0.0107	CcSEcCtD
Acebutolol—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000232	0.0105	CcSEcCtD
Acebutolol—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00023	0.0104	CcSEcCtD
Acebutolol—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000229	0.0104	CcSEcCtD
Acebutolol—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000225	0.0102	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000216	0.00977	CcSEcCtD
Acebutolol—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000214	0.0097	CcSEcCtD
Acebutolol—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000212	0.00963	CcSEcCtD
Acebutolol—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000211	0.00956	CcSEcCtD
Acebutolol—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00021	0.00953	CcSEcCtD
Acebutolol—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000208	0.00944	CcSEcCtD
Acebutolol—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000206	0.00932	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000204	0.00926	CcSEcCtD
Acebutolol—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000204	0.00924	CcSEcCtD
Acebutolol—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000202	0.00917	CcSEcCtD
Acebutolol—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000202	0.00917	CcSEcCtD
Acebutolol—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000195	0.00884	CcSEcCtD
Acebutolol—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000193	0.00877	CcSEcCtD
Acebutolol—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000188	0.00852	CcSEcCtD
Acebutolol—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000187	0.00848	CcSEcCtD
Acebutolol—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000187	0.00848	CcSEcCtD
Acebutolol—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00017	0.00769	CcSEcCtD
Acebutolol—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000167	0.00759	CcSEcCtD
Acebutolol—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000162	0.00734	CcSEcCtD
Acebutolol—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000156	0.00709	CcSEcCtD
Acebutolol—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00015	0.00682	CcSEcCtD
Acebutolol—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000149	0.00676	CcSEcCtD
Acebutolol—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000149	0.00675	CcSEcCtD
Acebutolol—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000148	0.00672	CcSEcCtD
Acebutolol—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000141	0.00637	CcSEcCtD
